Ország: Malajzia
Nyelv: angol
Forrás: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
BETAMETHASONE DIPROPIONATE
ORGANON MALAYSIA SDN. BHD.
BETAMETHASONE DIPROPIONATE
100gm mcg/mL
Organon Heist bv
_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP) _ DIPROCEL OINTMENT Betamethasone dipropionate (0.05% w/w) 1 Copyright 2023 Organon group of companies. All rights reserved. WHAT IS IN THIS LEAFLET 1. What Diprocel ointment is used for 2. How Diprocel ointment works 3. Before you use Diprocel ointment 4. How to use Diprocel ointment 5. While you are using Diprocel ointment 6. Side effects 7. Storage and Disposal of Diprocel ointment 8. Product description 9. Manufacturer and Product Registration Holder 10. Date of Revision WHAT DIPROCEL OINTMENT IS USED FOR Diprocel ointment is used to relief the inflammation symptoms caused by certain skin problems responding to corticosteroid including resistant or severe psoriasis. Psoriasis is a skin disease in which itchy, scaly, red patches develop on the elbows, knees, scalp and other parts of the body. HOW DIPROCEL OINTMENT WORKS Diprocel ointment contains the active ingredient betamethasone dipropionate. Betamethasone dipropionate belongs to a group of medicines called topical corticosteroids which are used on the surface of the skin to reduce the inflammation and itchiness caused by certain skin problems. BEFORE YOU USE DIPROCEL OINTMENT - _When you must not use it _ Do not use Diprocel ointment: • If you are allergic (hypersensitive) to its active ingredient betamethasone dipropionate, or to any of its ingredients (See full list in “ _Ingredients_ ”), or to similar medicines. • Side effects that may happen with oral or injectable corticosteroids may also occur with topical corticosteroids, especially in infants and children. _- Before you start to use it _ • Talk to your doctor or pharmacist before using Diprocel ointment. • This medicine should not be used under bandages or plasters. PREGNANCY, BREASTFEEDING AND FERTILITY Medicines of this class should not be used on pregnant women in large amounts or for prolonged periods of time. Caution should be exercised when Diprocel ointment is used to nursing women. If you are pregnant or breastfeeding, think you m Olvassa el a teljes dokumentumot
LPC-OG1460-DPL-MTL-082017a Diprocel ® Ointment betamethasone dipropionate, 0.05% FOR DERMATOLOGIC USE ONLY DESCRIPTION: Each gram of DIPROCEL Ointment contains 0.64 mg betamethasone dipropionate (equivalent to 0.5 mg betamethasone) in a base consisting of propylene glycol monostearate, propylene glycol, white wax and white petrolatum. ACTIONS: DIPROCEL Ointment is effective because of its anti-inflammatory, antipruritic and vasoconstrictive actions. The glycol ointment vehicle increases penetration and enhances the local effectiveness of the betamethasone dipropionate. INDICATIONS AND USAGE: DIPROCEL Ointment is indicated for the relief of the inflammatory manifestations of resistant or severe psoriasis and corticosteroid-responsive dermatoses. DOSAGE AND ADMINISTRATION: A thin film of DIPROCEL Ointment should be applied to cover completely the affected area once daily, in the morning. DIPROCEL Ointment may also be applied twice daily, in the morning and at night, at the physician’s discretion. As with all highly active topical corticosteroid preparations, treatment should be discontinued when the dermatologic disorder is controlled. According to clinical response, duration of therapy may vary from a few days to a longer period of time. However, treatment should not be continued for more than four weeks without patient re-evaluation. ADVERSE REACTIONS: The most frequent side effect reported is mild to moderate transient folliculitis and is rare. Urticaria, increased redness of lesions, increased erythema, itching, vesiculation and pruritus have been reported. Other local adverse reactions that have been reported with the use of topical corticosteroids include: burning, irritation, dryness, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae and miliaria. Systemic adverse reactions, such as vision blurred, have also been reported with the use of topical corticosteroids. CONTRAINDICATIONS: DIPRO Olvassa el a teljes dokumentumot